Serum leptin in obese patients with Laron syndrome before and during IGF-I treatment.

Abstract excerpt

Fifteen patients with primary GH resistance (Laron syndrome, LS) were studied before and during 6 months of daily replacement treatment with IGF-I. The main findings were that patients with LS and normal or high serum GH binding protein (GHBP) were less obese than those with a negative GHBP, and that serum leptin levels varied with body mass as in other types of obesity.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carrier Proteins
• Share to Child
• Share to Child, Preschool